Academia

Latest News

Several therapies address both CKD and HF simultaneously, including RAS inhibitors, which have been shown to slow CKD progression and reduce HF hospitalizations. | Image credit: Katie Chizhevskaya - stock.adobe.com

Highlighting Interconnected Pathways, Emerging Therapies in CKD and HF

September 10th 2025

As the prevalence of both chronic kidney disease (CKD) and heart failure (HF) increases, therapies targeting shared pathways are one of the most promising strategies to alter the trajectory of these diseases.

Online Medical global network | Image Credit: © ipopba - stock.adobe.com

Integrating Research, Health Care, and Community at Scale to Address the Population Health Question

By Sanne J. Magnan, MD, PhD
Paul Hughes-Cromwick, MA, CBE

September 10th 2025

Most of the patients who experienced superior outcomes with atezolizumab and chemotherapy had higher levels of NOTCH1 expression. | Image credit: Pixel-Shot - stock.adobe.com

NOTCH1 Levels Impact Immune Response in SCLC

By Jared Kaltwasser

September 2nd 2025

The researchers emphasized that ferroptosis affects different lung cells in distinct but interconnected ways that may drive pulmonary fibrosis. | Image credit: mi_viri - stock.adobe.com

Iron Dysregulation and Ferroptosis as Novel Targets in Pulmonary Fibrosis

By AJMC Contributor

August 29th 2025

While the findings are preliminary, clinicians may want to consider screening patients with chronic urticaria for metabolic syndrome as a part of their routine care. | Image credit: inthasone - stock.adobe.com

Patients With Chronic Urticaria May Face Higher Risk of Metabolic Syndrome

By Jared Kaltwasser

August 27th 2025

...

9 10 11 12 13

259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831

Do Not Sell My Information

Terms & Conditions